The store will not work correctly when cookies are disabled.
(1R,2S,3R,5R)-methyl 3-(4-iodophenyl)-8-aza-bicyclo[3.2.1]octane-2-carboxylate
ID: ALA398370
PubChem CID: 44431734
Max Phase: Preclinical
Molecular Formula: C15H18INO2
Molecular Weight: 371.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)[C@@H]1[C@H]2CC[C@H](C[C@H]1c1ccc(I)cc1)N2
Standard InChI: InChI=1S/C15H18INO2/c1-19-15(18)14-12(8-11-6-7-13(14)17-11)9-2-4-10(16)5-3-9/h2-5,11-14,17H,6-8H2,1H3/t11-,12+,13-,14+/m1/s1
Standard InChI Key: IBOZZWGMZPMXBO-RQJABVFESA-N
Molfile:
RDKit 2D
21 23 0 0 1 0 0 0 0 0999 V2000
5.7161 -8.5424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3598 -9.7336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0657 -9.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1713 -8.7062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3911 -7.8994 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5787 -8.9220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3895 -9.1374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1231 -9.0575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4356 -10.5551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7590 -11.0275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8343 -11.8482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5843 -12.1942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2598 -11.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1811 -10.8941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3229 -8.5659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0034 -9.0323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3866 -7.7434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7476 -8.6762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2958 -7.9542 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
4.3708 -8.4875 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.6611 -13.0156 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
9 10 2 0
3 4 1 0
10 11 1 0
4 5 1 0
11 12 2 0
5 1 1 0
12 13 1 0
1 6 1 0
13 14 2 0
14 9 1 0
6 2 1 0
6 15 1 1
4 7 1 0
15 16 1 0
1 8 1 0
15 17 2 0
7 8 1 0
16 18 1 0
1 19 1 6
2 9 1 6
4 20 1 6
2 3 1 0
12 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 371.22 | Molecular Weight (Monoisotopic): 371.0382 | AlogP: 2.69 | #Rotatable Bonds: 2 |
Polar Surface Area: 38.33 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.96 | CX LogP: 3.06 | CX LogD: 0.58 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.64 | Np Likeness Score: 0.68 |
References
1. Zeng F, Stehouwer JS, Jarkas N, Voll RJ, Williams L, Camp VM, Votaw JR, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM.. (2007) Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents., 17 (11): [PMID:17446069] [10.1016/j.bmcl.2007.03.056] |